Envision Pharma Group appoints new CEO
Envision Pharma Group is pleased to announce the appointment of Meg Heim as its new Chief Executive Officer. Throughout her career she has championed the professionalism of medical affairs and the innovations that improve patient experience.
Meg Heim
Working closely with an experienced Executive Leadership Team, Meg will be responsible for delivering an ambitious five-year plan that will reinforce Envision a the global leader in scientific and commercialization strategy and solutions, medical affairs, and lifecycle planning.
Meg said: “I am energized to be joining Envision Pharma Group at such an important time in the industry. I see a clear opportunity for further growth building off established and new opportunities in the sector. The company has an exceptional team and client base, and I am looking forward to spending time with our people, our clients, and other key partners.”
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
